Sergio Bernasconi

Prof. Sergio Bernasconi

University of Parma, Parma, Emilia-Romagna, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2018 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Giuliana ValerioGiuliana Valerio
Giuliana Valerio
CMClaudio Maffeis
Claudio Maffeis
GSGiuseppe Saggese
Giuseppe Saggese
MAMaria Amalia Ambruzzi
Maria Amalia Ambruzzi
ABAntonio Balsamo
Antonio Balsamo
EZEugenio Zito
Eugenio Zito
The Italian Consensus Position Statement on Diagnosis, Treatment and Prevention of Obesity in Children and Adolescents integrates and updates the previous guidelines to deliver an evidence based approach to the disease. The following areas were reviewed: (1) obesity definition and causes of secondary obesity; (2) physical and psychosocial comorbidities; (3) treatment and care settings; (4) prevention. The main novelties deriving from the Italian experience lie in the definition, screening of the cardiometabolic and hepatic risk factors and the endorsement of a staged approach to treatment. The evidence based efficacy of behavioral intervention versus pharmacological or surgical treatments is reported. Lastly, the prevention by promoting healthful diet, physical activity, sleep pattern, and environment is strongly recommended since the intrauterine phase.

Verified
Journal Article
Open access
PDF file
Maria E StreetMaria E Street
Maria E Street
Sergio BernasconiSergio Bernasconi
Sergio Bernasconi
Fetal growth is regulated by a complex interaction of maternal, placental, and fetal factors. The effects and outcomes that chemicals, widely distributed in the environment, may have on the health status of both the mother and the fetus are not yet well defined. Mainly mixtures of chemical substances are found in the mothers and placenta. Exposure to endocrine-disrupting chemicals (EDCs) can be associated with fetal growth retardation, thyroid dysfunction, and neurological disorders. EDCs mostly interfere with insulin, glucocorticoid, estrogenic, and thyroid pathways, with subsequent effects on normal endocrine and metabolic functions, which cause changes in the epigenome and state of inflammation with life-long effects and consequences. International scientific societies recommend the implementation of research and of all possible preventive measures. This review briefly summarizes all these aspects.

Verified
Journal Article
Open access
PDF file
Barbara PREDIERIBarbara PREDIERI
Barbara PREDIERI
Lorenzo IughettiLorenzo Iughetti
Lorenzo Iughetti
Sergio BernasconiSergio Bernasconi
Sergio Bernasconi
Maria E StreetMaria E Street
Maria E Street
Thousands of natural or manufactured chemicals were defined as endocrine-disrupting chemicals (EDCs) because they can interfere with hormone activity and the endocrine system. We summarize and discuss what we know and what we still need to learn about EDCs’ pathogenic mechanisms of action, as well as the effects of the most common EDCs on endocrine system health in childhood. The MEDLINE database (PubMed) was searched on 13 May 2022, filtering for EDCs, endocrine diseases, and children. EDCs are a group of compounds with high heterogeneity, but usually disrupt the endocrine system by mimicking or interfering with natural hormones or interfering with the body’s hormonal balance through other mechanisms. Individual EDCs were studied in detail, while humans’ “cocktail effect” is still unclear. In utero, early postnatal life, and/or pubertal development are highly susceptible periods to exposure. Human epidemiological studies suggest that EDCs affect prenatal growth, thyroid function, glucose metabolism, obesity, puberty, and fertility through several mechanisms. Further studies are needed to clarify which EDCs can mainly act on epigenetic processes. A better understanding of EDCs’ effects on human health is crucial to developing future regulatory strategies to prevent exposure and ensure the health of children today, in future generations, and in the environment.

6 June 2019 in Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
SDSabrina Duranti
Sabrina Duranti
Gabriele Andrea LugliGabriele Andrea Lugli
Gabriele Andrea Lugli
Christian MilaniChristian Milani
Christian Milani
KJKieran James
Kieran James
LMLeonardo Mancabelli
Leonardo Mancabelli
MVMarco Ventura
Marco Ventura

1 September 2004 in Journal of Clinical Investigation
Verified
Journal Article
Open access
MCMaria Rosaria Cera
Maria Rosaria Cera
APANNALISA DEL PRETE
ANNALISA DEL PRETE
AVAnnunciata Vecchi
Annunciata Vecchi
MCMonica Corada
Monica Corada
IMInes Martin-Padura
Ines Martin-Padura
EDElisabetta Dejana
Elisabetta Dejana
Junctional adhesion molecule-A (JAM-A) is a transmembrane adhesive protein expressed at endothelial junctions and in leukocytes. In the present work, we found that DCs also express JAM-A. To evaluate the biological relevance of this observation, Jam-A–/– mice were generated and the functional behavior of DCs in vitro and in vivo was studied. In vitro, Jam-A–/– DCs showed a selective increase in random motility and in the capacity to transmigrate across lymphatic endothelial cells. In vivo, Jam-A–/– mice showed enhanced DC migration to lymph nodes, which was not observed in mice with endothelium-restricted deficiency of the protein. Furthermore, increased DC migration to lymph nodes was associated with enhanced contact hypersensitivity (CHS). Adoptive transfer experiments showed that JAM-A–deficient DCs elicited increased CHS in Jam-A+/+ mice, further supporting the concept of a DC-specific effect. Thus, we identified here a novel, non-redundant role of JAM-A in controlling DC motility, trafficking to lymph nodes, and activation of specific immunity.

1 January 2020
Verified
Book Chapter
Open access
Maria E StreetMaria E Street
Maria E Street
SBSergio Bernasconi
Sergio Bernasconi